{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0019973/ORPHA:97341","label":"Persistent placoid maculopathy","mondoId":"MONDO:0019973","onsetQualifier":null,"recordKeys":["16b6d1731ecc5852bcd39b5f0a172f179bb5fd353a8006557fdf74c06c8fb430","3b3f2d5da139d604ba8bc27be294cf499d2c34fd3642d4af5e15947c4365bf07","606e408006935bbab5b3cb7c0aebb860423cc7ffed15c8706e3668bf84f4ad44","6bee37f834d93b02cce959d69311f386375fa8a3e83d0323a06be88dacde325d","963d428f8b1668fc0275cdc93713b65fcfaeadf0d12ab1c404865b223d2e9aa7","9c7ef7a0d505fc77d86ce4c50532aee20f5284930b9a7472b59a0d11b7cddafc","e8e831a5abc2ff3a69885f1bc224499e00d462c9642162d2096a06ca73b67784","edd920214afb0373560e082b8a47bff968b8c5acbc8e759f0227009d23876920"],"recordQualifiers":{},"scopeLabel":"ORPHA:97341","sourceIds":["ORPHA:97341"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0019973/ORPHA:97341"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"omim":0,"orphanet":8,"published":0}},"features":[{"hpoId":"HP:0001103","label":"Abnormal macular morphology","primary":false},{"hpoId":"HP:0000646","label":"Amblyopia","primary":false},{"hpoId":"HP:0011506","label":"Choroidal neovascularization","primary":false},{"hpoId":"HP:0007750","label":"Hypoplasia of the fovea","primary":false},{"hpoId":"HP:0012508","label":"Metamorphopsia","primary":false},{"hpoId":"HP:0007663","label":"Reduced visual acuity","primary":false},{"hpoId":"HP:0007814","label":"Retinal pigment epithelial mottling","primary":false},{"hpoId":"HP:0010822","label":"Scintillating scotoma","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0019973","records":[{"frequencyKind":"range","key":"16b6d1731ecc5852bcd39b5f0a172f179bb5fd353a8006557fdf74c06c8fb430","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010822","is_excluded":false,"label":"Scintillating scotoma","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b3f2d5da139d604ba8bc27be294cf499d2c34fd3642d4af5e15947c4365bf07","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0007663","is_excluded":false,"label":"Reduced visual acuity","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"606e408006935bbab5b3cb7c0aebb860423cc7ffed15c8706e3668bf84f4ad44","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000646","is_excluded":false,"label":"Amblyopia","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6bee37f834d93b02cce959d69311f386375fa8a3e83d0323a06be88dacde325d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001103","is_excluded":false,"label":"Abnormal macular morphology","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"963d428f8b1668fc0275cdc93713b65fcfaeadf0d12ab1c404865b223d2e9aa7","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012508","is_excluded":false,"label":"Metamorphopsia","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9c7ef7a0d505fc77d86ce4c50532aee20f5284930b9a7472b59a0d11b7cddafc","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0011506","is_excluded":false,"label":"Choroidal neovascularization","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e8e831a5abc2ff3a69885f1bc224499e00d462c9642162d2096a06ca73b67784","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007750","is_excluded":false,"label":"Hypoplasia of the fovea","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edd920214afb0373560e082b8a47bff968b8c5acbc8e759f0227009d23876920","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:97341","disease_name":"Persistent placoid maculopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007814","is_excluded":false,"label":"Retinal pigment epithelial mottling","onset_id":null,"reference":"ORPHA:97341","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"persistent-placoid-maculopathy","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"persistent placoid maculopathy"},"schemaVersion":1}